| Literature DB >> 26087793 |
Yuusaku Sugihara1,2, Shin-ei Kudo1, Hideyuki Miyachi1, Masashi Misawa1, Shogo Okoshi1, Hiroyuki Okada2, Kazuhide Yamamoto2.
Abstract
BACKGROUND/AIMS: Diverticular bleeding can occasionally cause massive bleeding that requires urgent colonoscopy (CS) and treatment. The aim of this study was to identify significant risk factors for colonic diverticular hemorrhage.Entities:
Keywords: Anti-inflammatory agents, non-steroidal; Cerebrovascular disease; Colonoscopy; Diverticular bleeding; Hyperuricemia
Mesh:
Substances:
Year: 2016 PMID: 26087793 PMCID: PMC4780454 DOI: 10.5009/gnl14407
Source DB: PubMed Journal: Gut Liver ISSN: 1976-2283 Impact factor: 4.519
Fig. 1Clinical data regarding the patients enrolled in the present study. CS, colonoscopy.
Source of Acute Lower Gastrointestinal Bleeding
| Disease | No. | % | Male/female |
|---|---|---|---|
| Diverticular hemorrhage | 72 | 58.5 | 51/21 |
| Ileum hemorrhage | 8 | 6.5 | 5/3 |
| Ischemic colitis | 7 | 5.7 | 4/3 |
| Inflammatory bowel disease | 6 | 4.9 | 5/1 |
| Hemorrhoids | 5 | 4.1 | 3/2 |
| Infection colitis | 4 | 3.3 | 2/2 |
| Anastomotic hemorrhage | 4 | 3.3 | 2/2 |
| Solitary rectal ulcer | 3 | 2.4 | 2/3 |
| Carcinoma | 3 | 2.4 | 2/2 |
| Sigmoid volvulus | 3 | 2.4 | 2/0 |
| Unknown | 4 | 3.3 | 2/2 |
| Others | 4 | 3.3 | 2/2 |
| Total | 123 | 80/43 |
Background Factors of the Cases and Controls
| Factor | Cases | Controls | p-value |
|---|---|---|---|
| No. | 72 | 149 | - |
| Male/female | 51/21 | 91/58 | - |
| Average age (range), yr | 70 (33–92) | 70 (37–92) | - |
| Location of diverticula (L/R) | 24/48 | 77/72 | - |
| Body mass index, kg/m2 | 21.3 | 22.8 | NS |
| Smoking | 10 | 18 | NS |
| Alcohol | 14 | 40 | NS |
L, left hemicolon; R, right hemicolon; NS, not significant.
Risk Factors for Diverticular Hemorrhage by Univariate Analysis
| Factor | Cases (n=72) | Controls (n=149) | OR | 95% CI | p-value |
|---|---|---|---|---|---|
| Past history | |||||
| Diabetes mellitus | 14 | 18 | 1.398 | 0.556–3.389 | 0.5177 |
| Hypertension | 36 | 42 | 2.399 | 1.287–4.498 | 0.0041 |
| Hyperlipidemia | 6 | 10 | 1.262 | 0.361–4.026 | 0.7825 |
| Ischemic heart disease | 17 | 14 | 2.964 | 1.277–6.993 | 0.0067 |
| Cerebrovascular disease | 14 | 4 | 2.325 | 0.682–3.410 | 0.0006 |
| Chronic renal disease | 6 | 7 | 1.839 | 0.489–6.672 | 0.3606 |
| Osteoporosis | 1 | 2 | 2.092 | 0.149–29.412 | 0.5978 |
| Hyperuricemia | 8 | 1 | 18.266 | 2.368–822.732 | 0.0006 |
| Medication | |||||
| NSAIDs | 19 | 3 | 17.194 | 4.786–94.425 | <0.0001 |
| Antithrombotic agents | 29 | 20 | 4.316 | 2.120–8.964 | <0.0001 |
OR, odds ratio; CI, confidence interval; NSAIDs, nonsteroidal anti-inflammatory drugs.
Risk Factors for Diverticular Hemorrhage by Multivariate Analysis
| Factor | OR | 95% CI | p-value |
|---|---|---|---|
| Hypertension | 1.56 | 0.760–3.190 | 0.226 |
| Ischemic heart disease | 1.64 | 0.496–5.430 | 0.418 |
| Cerebrovascular disease | 8.66 | 2.330–32.100 | 0.00126 |
| Hyperuricemia | 15.5 | 1.740–138.000 | 0.014 |
| NSAIDs | 14.70 | 3.890–55.800 | <0.0001 |
| Antithrombotic agents | 1.32 | 0.463–3.750 | 0.604 |
OR, odds ratio; CI, confidence interval; NSAIDs, nonsteroidal anti-inflammatory drugs.
Risk Factors for Diverticular Hemorrhage in the Definite Group
| Factor | Cases | Controls | OR | 95% CI | p-value |
|---|---|---|---|---|---|
| Univariate analysis in the cases and controls of the definite group | |||||
| Past history | 26 | 54 | |||
| Diabetes mellitus | 5 | 7 | 1.599 | 0.454–5.623 | 0.4647 |
| Hypertension | 15 | 13 | 4.301 | 1.587–11.659 | 0.0041 |
| Hyperlipidemia | 3 | 4 | 1.631 | 0.337–7.887 | 0.5433 |
| Ischemic heart disease | 8 | 4 | 5.556 | 1.491–20.703 | 0.0106 |
| Cerebrovascular disease | 5 | 2 | 6.191 | 1.112–34.444 | 0.0373 |
| Chronic renal disease | 1 | 2 | 1.04 | 0.09–12.022 | 0.9748 |
| Osteoporosis | 1 | 0 | - | - | - |
| Hyperuricemia | 5 | 2 | 6.191 | 1.113–34.444 | 0.0374 |
| Medication | |||||
| NSAIDs | 7 | 1 | 19.526 | 2.252–169.277 | 0.0070 |
| Antithrombotic agents | 13 | 8 | 5.75 | 1.963–16.840 | 0.0014 |
| Multivariate analysis in the cases and controls in the definite group | |||||
| Hypertension | 15 | 13 | 3.785 | 1.053–13.6 | 0.0414 |
| Ischemic heart disease | 8 | 4 | 8.28 | 0.502–136.65 | 0.1395 |
| Cerebrovascular disease | 5 | 2 | 9.964 | 0.677–146.654 | 0.0938 |
| Hyperuricemia | 5 | 2 | 5.594 | 0.612–51.101 | 0.1271 |
| NSAIDs | 7 | 1 | 16.766 | 1.529–183.747 | 0.0210 |
| Antithrombotic agents | 13 | 8 | 1.18 | 0.1–13.936 | 0.8953 |
OR, odds ratio; CI, confidence interval; NSAIDs, nonsteroidal anti-inflammatory drugs.
Risk Factors for Diverticular Hemorrhage in the Presumptive Group
| Factor | Cases | Controls | OR | 95% CI | p-value |
|---|---|---|---|---|---|
| Univariate analysis in the cases and controls in the presumptive group | |||||
| Past history | 46 | 106 | |||
| Diabetes mellitus | 9 | 14 | 1.599 | 0.637–4.012 | 0.3177 |
| Hypertension | 21 | 28 | 2.34 | 1.135–4.823 | 0.0212 |
| Hyperlipidemia | 3 | 12 | 0.547 | 0.146–2.037 | 0.3681 |
| Ischemic heart disease | 9 | 12 | 1.906 | 0.741–4.899 | 0.1807 |
| Cerebrovascular disease | 9 | 0 | - | - | - |
| Chronic renal disease | 5 | 2 | 6.341 | 1.183–34.017 | 0.0311 |
| Osteoporosis | 0 | 0 | - | - | - |
| Hyperuricemia | 3 | 2 | 3.628 | 0.585–22.483 | 0.1661 |
| Medication | |||||
| NSAIDs | 12 | 2 | 18.352 | 3.910–86.136 | 0.0002 |
| Antithrombotic agents | 16 | 12 | 4.178 | 1.779–9.813 | 0.0011 |
| Multivariate analysis in the cases and controls in the presumptive group | |||||
| Hypertension | 21 | 28 | 2.711 | 1.133–6.489 | 0.0251 |
| Ischemic heart disease | 9 | 12 | 1.317 | 0.423–4.091 | 0.6341 |
| Chronic renal disease | 5 | 2 | 1.625 | 0.206–12.802 | 0.6445 |
| Hyperuricemia | 3 | 2 | 0.92 | 0.098–8.602 | 0.9419 |
| NSAIDs | 12 | 2 | 19.665 | 3.797–101.843 | 0.0004 |
| Antithrombotic agents | 16 | 12 | 4.828 | 1.603–14.536 | 0.0051 |
OR, odds ratio; CI, confidence interval; NSAIDs, nonsteroidal anti-inflammatory drugs.